key: cord-0527811-o0gp17g9
authors: Patwa, Parth; Reddy, Viswanatha; Sukumaran, Rohan; Sethuraman, TV; Nashnoush, Eptehal; Shankar, Sheshank; Kaur, Rishemjit; Singh, Abhishek; Raskar, Ramesh
title: Can Self Reported Symptoms Predict Daily COVID-19 Cases?
date: 2021-05-18
journal: nan
DOI: nan
sha: 917a4365e4a6dc5ecc95949ffa5d562917348f0a
doc_id: 527811
cord_uid: o0gp17g9

The COVID-19 pandemic has impacted lives and economies across the globe, leading to many deaths. While vaccination is an important intervention, its roll-out is slow and unequal across the globe. Therefore, extensive testing still remains one of the key methods to monitor and contain the virus. Testing on a large scale is expensive and arduous. Hence, we need alternate methods to estimate the number of cases. Online surveys have been shown to be an effective method for data collection amidst the pandemic. In this work, we develop machine learning models to estimate the prevalence of COVID-19 using self-reported symptoms. Our best model predicts the daily cases with a mean absolute error (MAE) of 226.30 (normalized MAE of 27.09%) per state, which demonstrates the possibility of predicting the actual number of confirmed cases by utilizing self-reported symptoms. The models are developed at two levels of data granularity - local models, which are trained at the state level, and a single global model which is trained on the combined data aggregated across all states. Our results indicate a lower error on the local models as opposed to the global model. In addition, we also show that the most important symptoms (features) vary considerably from state to state. This work demonstrates that the models developed on crowd-sourced data, curated via online platforms, can complement the existing epidemiological surveillance infrastructure in a cost-effective manner. The code is publicly available at https://github.com/parthpatwa/Can-Self-Reported-Symptoms-Predict-Daily-COVID-19-Cases.

The COVID-19 pandemic has created turmoil in the lives of millions of people across the globe. Even with the advent of vaccines, their distribution remains a challenge [Bae et al., 2020; Chirag et al., 2021; Mills and Salisbury, 2021] . We need interventions, policies, and solutions that go beyond * Contact Author pharmaceutical interventions (vaccines, therapeutics, etc) . Testing and identifying the number of COVID-19 cases is important for us to identify how well we are doing against the virus. Although important, even with rapid tests and at-home testing facilities, we are testing less than 5.61 per 1000 of the population in the US [Appel et al., 2021; Morales et al., 2021; . Furthermore, getting test results takes time in hours, which can lead to delays in getting medical treatment. This calls for a non-invasive, and scalable method for estimating the cases, to complement traditional testing infrastructure. In this paper, we harness the power of deep learning and crowd-sourced symptoms data for the prediction of COVID 19 cases on a daily basis. For this purpose, we use the data collected by CMU via Facebook surveys [CMU, 2020] . This data of self-reported symptoms is available at the state level for the US. We integrate this self-reported symptoms data with the actual COVID-19 cases reported by WHO.

Here, we answer an important question "Can we predict daily COVID-19 cases at the granularity of a state, using selfreported symptoms from a fraction of the population?".

We predict the actual daily case count, using self-reported symptoms data that is aggregated at the population level (to obfuscate personal information), by training machine learning (ML) and deep learning (DL) algorithms. We train models at two levels of data granularity -global and local. At the global level, we combine the data from all the states into a single data set and train a single model on it, whereas at the local level, we train a separate model for each state. At the global level, the best model has a mean absolute error (MAE) of 368.26 and normalized MAE (nMAE) of 44.08%. Further, when we take an ensemble of all the local models, the MAE reduces to 226.30 per state (nMAE = 27.09%). This indicates that the model is off by 226 cases per state when predicting daily cases. The success of our experiments highlights the fact that our model can serve as a low resource way of estimating COVID-19 cases. We observe that the top features contributing to predictions vary from state to state, alluding to the benefits of local models. Our model may be used to detect hot spots and can act as a non-obtrusive, economical, and effective screening method in a low resource environment. vations, where the scientific community has focused on this disease with near-unprecedented intensity. Along the clinical direction, there were several efforts like vaccine development [Kaur and Gupta, 2020] , re-purposing known clinicallytested drugs, and virtual screening for possible targets using protein structure data [Keshavarzi Arshadi et al., 2020; Zhavoronkov et al., 2020] , understanding efficacy of testing [Jarrom et al., 2020] , etc. Efforts along clinical and other medical directions are instrumental but can be timeconsuming. The drastic increase in cases has challenged the medical infrastructure worldwide in various aspects, including a sharp rise in demand for hospital beds, shortage of medical equipment and personnel [Sen-Crowe et al., 2021] . At the same time, testing methods are also facing an acute shortage in developing countries. Thereby causing a delay in getting test results leading to increased infection rates and delays in critical preventive measures. Thus judicial usage of health care resources like testing, vaccines is crucial.

To complement the medical research with computational solutions, efforts have been made on predictive modelling of the disease spread, simulations on vaccine distribution strategies, etc [Romero-Brufau et al., 2021] . Many efforts were along the directions of understanding the severity, spread, and unique characteristics of the COVID-19 infection, across a broad range of clinical, imaging, and population-level datasets [Gostic et al., 2020; Liang et al., 2020; Menni et al., 2020b; Shi et al., 2020; . For instance, various studies have tried to understand the progression of the virus, future hot-spot, estimating the number of cases/deaths/hospitalization, etc. using exposure notification [Leith and Farrell, 2020] , epidemiological modeling [Romero-Brufau et al., 2021] . Studies have also tried mathematical modeling to understand the outbreak under different situations for different demographics [Menni et al., 2020a; Saad-Roy et al., 2020; Wilder et al., 2020] . Apart from these, several machine learning models were developed to forecast the COVID-19 cases in regions like India, Egypt [Farooq and Bazaz, 2021; Amar et al., 2020] , etc.

Effective screening enables quick and efficient diagnosis of COVID-19 and can mitigate the burden on public healthcare systems. Prediction models which combine several features (symptoms, testing, mobility, etc.) to estimate the risk of infection have been developed to assisting medical staff worldwide in triaging patients. Some of these models use laboratory tests [Feng et al., 2021; Mei et al., 2020] , clinical symptoms [Tostmann et al., 2020] , and integration of both [Punn et al., 2020] . However, most previous models were based on data from hospitalized patients and thus are not effective in screening for COVID-19 in the general population.

Hence, the development of non-obtrusive system disentangled from the health care infrastructure becomes imperative to accelerate the efforts against COVID-19. [Sukumaran et al., 2020] used self-reported symptoms to predict outbreaks and is the closest to our work. However, unlike their work, we predict actual daily cases instead of self-reported daily cases.

3 Data CMU dataset -We use the symptoms survey data from CMU [CMU, 2020] . This was a survey collected across 70,000 on a daily basis. It consists of multiple questions along the directions of symptoms (cough, fever, etc), behavioral patterns (working outside, avoid contact, etc), medical conditions (cancer, heart disease, etc), and more. They aggregate the data and provide it in the form of percentage of respondents who reported having that symptom/behavior. The data is available at the county and state level with a total of 104 features (as of October 2020), including weighted (adjusted for sampling bias), unweighted signals, demographic columns (age, gender, etc). We use the state level data from Apr. 4, '20 to Sep. 11, '20 .

Daily Cases -NY Times [Almukhtar et al., 2020] reports the cumulative number of cases in a state on a given date, as provided by WHO. From this data, we compute and use the daily new cases in a state.

We predict the daily cases of COVID-19 in the US states [Almukhtar et al., 2020] using data from 6 April 2020 to 11 September 2020.

Input Features -We use features provided in the CMU [CMU, 2020] dataset. We follow a feature selection and ranking process similar to . Further, we prune un-weighted and other signals (age, gender, derived features, etc) which leaves us with 35 features. We further rank these 35 features according to their f regression [Pedregosa et al., 2007] scores against the target variable, and then input them to the models. As the demographic level (age, gender) split of actual daily cases is not available, we drop such data points from the CMU data. Thereby, only using data points that aggregate all demographics (gender and age).

Data Granularity levels -We train on 2 levels:

• Global -The data of all the states is combined and a single model is trained.

• Local -A separate model is trained for every state. For comparison with the global level model, we ensemble the predictions from all the local models -for each state we take the test prediction from the respective local models. Thereby getting the local predictions from the respective local model. Later, we compute the error metrics for the entire test set.

Train-Test Split -We split the entire data into train/test set on the basis of dates. The train data has the initial 80% of the dates whereas the test data has the last 20% of the dates. This ensures that the model has not seen future dates while training. It also ensures that the train and test data of every state is the same in the local and global level model.

Algorithms -We experiment with five ML baselines -Linear Regression (LR), Decision Tree (DT), Multi Layer Perceptron (MLP), Gradient Boost (GDBT), and XGBoost (XGB). We also implement 2 DL models:

• CNN -An architecture with seven convolutional layers followed by dense layers. • 1d Resnet -Inspired by the wide success of ResNets [He et al., 2015] in various fields we have developed a model similar to ResNet-18 for one-dimensional data. Our proposed architecture comprises of 3 blocks. At the end of the network, a Global Average Pooling (GAP) layer is used followed by fully connected layers. The dense layers comprises of 256, 128, and 1 neuron respectively. Between each fully connected layer, a dropout layer is employed with a probability of 0.5 (p=0.5). Error Metric -We use two error metrics to evaluate and compare our models:

• Mean Absolute Error (MAE) -The average over all data points of the absolute value of the difference between the predicted value and the actual value. MAE = 1 n n i=1 |p i − t i | Where n is the total data instances, p i is the predicted value and t i is the actual value (ground truth).

• Normalized Mean Absolute Error (nMAE) -Normalized error is calculated to capture the variation in the number of daily cases across different dates and states.

To show statistical significance, we also calculate the 95% confidence interval (CI) over 20 runs (the random seed is changed every time) for our ML based global level models. Implementation -We use Scikit-learn [Pedregosa et al., 2011], Keras [Chollet and others, 2015] , and xgboost library [Chen and Guestrin, 2016] for our implementation. The ML models are trained on an Intel i7 8th generation CPU, while DL models are trained on Google Colab. The code is publicly available at https://github.com/parthpatwa/Can-Self-Reporte d-Symptoms-Predict-Daily-COVID-19-Cases. Table 1 shows the result of daily cases prediction by different models trained on the global level. Our 1D Resnet performs the best with 382.40 MAE and 45.77% nMAE per state. CNN performs worse than 1d resnet. Among ML models, XGB (MAE = 502.73 , nMAE = 60.15%) performs the best, while LR has the worst performance. Figure 1 shows the MAE vs the number of features used for XGB. It can be observed that with the increase in number of features, MAE decreases. However, MAE plateaus after incorporating approx. 15 features. Consequently, we can even use fewer (around 15) features to predict daily cases without considerably increasing the error. This observation is similar to that of and may aid in reducing the number of questions of the surveys. Table 3 shows the MAE of ensemble of models trained on the local level (one model per state). We see that 1d resnet performs the best and gives an MAE of 226.30 per state across the USA (nMAE = 27.09%). LR performs the worst.

We can see from Table 1 and Table 3 that for all algorithms except CNN, the ensemble of local models achieves substantially lower error than a single global model. For example, the MAE of XGB trained on global level is 452.12 (nMAE =54.10%) whereas MAE of XGB models trained on local level is 287.63 (nMAE = 34.43%). The poor results of local CNN models could be due to lack of data per state or overfitting. CNN fails to capture complex relations that generalize well. The superiority of local models over the global model is further observed in Table 4 which shows the statewise MAE by 1d Resnet trained on global and local level for a few states. Local level models outperform the the global level model in 49 states out of 50. These observations motivate us to analyze the state-wise top contributing features. Figure 2 shows the number of times a feature was in the top 5 or top 15 important features across the local models, based on the feature importance given by the XGB models. We see that cmnty cli (covid like illness in community), and avoid contact all or most time are important features for most of the local level models. However, the frequency of the remaining features being in the top 5 or top 15 features is low. 32 of the 35 features are present in top 5 for at least 1 state and all the features are in the top 15 for at least 9 states. This shows that the top important features vary considerably across the states. Table 2 shows some states having different set of top 5 features. As the feature importance (or ranking) varies considerably across the states, local models perform better than Model Top 5 features ca cmnty cli, avoid contact all or most time, hh fever, hh sore throat, hh cough tx cmnty cli, anosmia ageusia, avoid contact all or most time, worked outside home, high blood pressure fl cmnty cli, anosmia ageusia, avoid contact all or most time, worked outside home, persistent pain pressure in chest ak cmnty cli, worked outside home, avoid contact all or most time, self runny nose, none of above vt none of above, hh cough, cancer, nasal congestion, avoid contact all or most time wy avoid contact all or most time, self shortness of breath, cmnty cli, other, tiredness or exhaustion Global cmnty cli, anosmia ageusia, hh fever, hh cli, hh sore throat 

Forecasting the epidemic and its spread is an important tool in pandemic response. In this work, we assess the possibility of building an outbreak prediction system using crowdsourced symptoms data. Our experiments demonstrate that self-reported symptoms can predict actual cases with low error. Furthermore, a small number of features (symptoms) are sufficient to predict the total number of cases with reasonable accuracy. The analysis suggests that learning models at a state level improves the prediction performance possibly due to the top features vary across different states. In other words, COVID-19 affects every state differently. This information can be used to create state-specific and shorter surveys. Consequently, with the increasing social media and internet penetration, this method can be scaled to complement physical testing facilities to estimate the number of cases, especially in low resource areas. Future directions worth exploring include, improving the prediction capability of the model by incorporating meta learning and transfer learning to improve performance for states with relatively lower number of samples, and to forecast cases as a time series. As the data collected here is health data, privacy-preserving machine learning could improve the adoption of such systems.

We thank Ishaan Singh for help in drafting this paper. 

Prediction of the final size for covid-19 epidemic using machine learning: A case study of egypt

Challenges of equitable vaccine distribution in the covid-19 pandemic

Vaccination worldwide: Strategies, distribution and challenges

Junaid Farooq and Mohammad Abid Bazaz. A deep learning algorithm for modeling and forecasting of covid-19 in five worst affected states of india

A novel triage tool of artificial intelligence-assisted diagnosis aid system for suspected covid-19 pneumonia in fever clinics. medRxiv, 2021

Covid-19 vaccine: A comprehensive status report

Jianxing He, and for the China Medical Treatment Expert Group for COVID-19. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

Artificial intelligence-enabled rapid diagnosis of patients with covid-19

Covid-19 tests gone rogue: Privacy, efficacy, mismanagement and misunderstandings

Public health impact of delaying second dose of bnt162b2 or mrna-1273 covid-19 vaccine: simulation agent based modeling study

A closer look into global hospital beds capacity and resource shortages during the covid-19 pandemic

Strong associations and moderate predictive value of early symptoms for sars-cov-2 test positivity among healthcare workers, the netherlands